Delivery Order SPE2DE21D0007-SPE2D625F3C3K
Award Date
4/17/25
Potential Completion Date
5/7/25
Potential Value
$5K
Federal Agency
Medical Supply Chain
Awardee
Ortho-Clinical Diagnostics, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,418.30 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, by the Defense Health Agency for blood group serum supplies. The order has a period of performance ending on November 29, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs and...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract is for the delivery of Blood Group Serum 15S, with a ceiling value of $2,904.77 and a period of performance ending on May 7, 2025. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. It does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of "BLOOD GROUP SERUM" to the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The $1,767.32 fixed-price with economic price adjustment contract was awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturing company. The contract has an ultimate completion date of October 31, 2024 and does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. has provided...
This is a $849,897.70 firm fixed-price purchase order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for blood bank testing supplies and services, with a period of performance ending on September 30, 2028. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has been awarded multiple Indefinite...
This is a $57,096.46 firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 23 (VISN 23) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of Ortho blood bank reagents and gel cards approved for use with the Ortho gel workstation. The contract has an ultimate completion date of September 30, 2027. No set-aside designation was used for this award. Ortho-Clinical Diagnostics, Inc. is a...
This is a $1,832.54 delivery order awarded by the Medical Supply Chain, a division of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of "ANTI-A BIOCLONE 15X10ML", a medical diagnostic product, with a period of performance through May 2025. The contract has a fixed price with economic price adjustment pricing type and does not utilize any set-aside designations. Ortho-Clinical Diagnostics, Inc. is a...
This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer registered in SAM.gov. The contract is for the delivery of 4567683435 ! ANTI-B BIOCLONE 15X10ML products, with a completion date of March 27, 2025. This appears to be a delivery order contract with a fixed price with economic price adjustment pricing type. The contract does not utilize any...
This is a $1,767.32 fixed-price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer registered in SAM.gov as a self-certified HUBZone joint venture. The contract is for the supply of anti-A,B bioclone laboratory reagents, with a period of performance through February 2025. Ortho-Clinical Diagnostics has demonstrated the capability to provide critical medical diagnostic...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
This is a $1,255.63 fixed-price delivery order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The contract is for the supply of "ANTI-M 1X5ML" medical products, with a period of performance through April 23, 2025. The contract does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a key supplier of sophisticated...